Table 2.
Univariate analysis: Demographic, clinical and treatment variables according to the presence/absence of esophagitis
| Variable | Presence of esophagitis (n = 154) | No esophagitis (n = 1207) | p value |
|---|---|---|---|
| Age (mean ± SD) | 50.2 ± 16.5 | 53.4 ± 17.1 | 0.03 |
| Gender (male/female) (%) | 16/7 | 84/93 | 0.000 |
| BMI (kg/m2) (mean ± SD) | 26.8 ± 5 | 26.1 ± 5 | 0.049 |
| Weight (kg) (mean ± SD) | 76.5 ± 16 | 71.1 ± 16 | 0.000 |
| Height (cm) (mean ± SD) | 168.9 ± 9.3 | 164.9 ± 9.4 | 0.000 |
| Increased waist circumference | 11.8% | 7.8% | 0.045 |
| Alcohol (>20 units/week) | 28.9% | 10.8% | 0.002 |
| Smoking (>10 cigarettes/day) | 14.3% | 14.3% | 1 |
| Number of comorbidities | 0.29 ± 0.7 | 0.4 ± 0.8 | 0.07 |
| PPIs | 52.6% | 54.6% | 0.35 |
| NSAID | 15.6% | 15.3% | 0.5 |
| AAS | 6.9% | 6.5% | 0.51 |
| GERD-Q Score (Mean ± SD) | 8.7 ± 3.1 | 7.1 ± 2.5 | 0.000 |
BMI: body mass index; GERD: gastro-esophageal reflux disease; PPI: proton pump inhibitors; NSAID: nonsteroidal anti-inflammatory drug; AAS: acetyl salicylic acid; SD: standard deviation.